A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action. / Madsen, Andreas Stahl; Olsen, Christian Adam.

I: MedChemComm, Bind 7, 2016, s. 464-470.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Madsen, AS & Olsen, CA 2016, 'A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action', MedChemComm, bind 7, s. 464-470. https://doi.org/10.1039/c5md00451a

APA

Madsen, A. S., & Olsen, C. A. (2016). A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action. MedChemComm, 7, 464-470. https://doi.org/10.1039/c5md00451a

Vancouver

Madsen AS, Olsen CA. A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action. MedChemComm. 2016;7:464-470. https://doi.org/10.1039/c5md00451a

Author

Madsen, Andreas Stahl ; Olsen, Christian Adam. / A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action. I: MedChemComm. 2016 ; Bind 7. s. 464-470.

Bibtex

@article{b7068648ee4e4ccfacd68a5f734c18d4,
title = "A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action",
abstract = "Histone deacetylase (HDAC) enzymes are validated targets for treatment of certain cancers and have potential as targets for pharmacological intervention in a number of other diseases. Thus, inhibitors of these enzymes have received considerable attention, but these are often evaluated by IC50 value determination, which may vary significantly depending on assay conditions. In this work, we therefore performed detailed kinetic evaluation of inhibitors containing two fundamentally different zinc-binding chemotypes, hydroxamic acid or trifluoromethyl ketone. For the hydroxamic acids, a fast-on–fast-off mechanism was observed, but the trifluoromethyl ketone compound exhibited differential mechanisms depending on the enzyme isoform. The trifluoromethyl ketone compound displayed a fast-on–fast-off mechanism against class-IIa HDACs 4 and 7, but slow-binding mechanisms against class-I and class-IIb enzymes (HDACs 1–3, 6 and 8). Furthermore, different competitive, slow-binding mechanisms were observed for HDACs 1, 2, and 6 vs. HDACs 3 and 8, demonstrating the power of kinetic experiments for characterisation of enzyme inhibitors.",
author = "Madsen, {Andreas Stahl} and Olsen, {Christian Adam}",
year = "2016",
doi = "10.1039/c5md00451a",
language = "English",
volume = "7",
pages = "464--470",
journal = "MedChemComm",
issn = "2040-2503",
publisher = "Royal Society of Chemistry",

}

RIS

TY - JOUR

T1 - A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action

AU - Madsen, Andreas Stahl

AU - Olsen, Christian Adam

PY - 2016

Y1 - 2016

N2 - Histone deacetylase (HDAC) enzymes are validated targets for treatment of certain cancers and have potential as targets for pharmacological intervention in a number of other diseases. Thus, inhibitors of these enzymes have received considerable attention, but these are often evaluated by IC50 value determination, which may vary significantly depending on assay conditions. In this work, we therefore performed detailed kinetic evaluation of inhibitors containing two fundamentally different zinc-binding chemotypes, hydroxamic acid or trifluoromethyl ketone. For the hydroxamic acids, a fast-on–fast-off mechanism was observed, but the trifluoromethyl ketone compound exhibited differential mechanisms depending on the enzyme isoform. The trifluoromethyl ketone compound displayed a fast-on–fast-off mechanism against class-IIa HDACs 4 and 7, but slow-binding mechanisms against class-I and class-IIb enzymes (HDACs 1–3, 6 and 8). Furthermore, different competitive, slow-binding mechanisms were observed for HDACs 1, 2, and 6 vs. HDACs 3 and 8, demonstrating the power of kinetic experiments for characterisation of enzyme inhibitors.

AB - Histone deacetylase (HDAC) enzymes are validated targets for treatment of certain cancers and have potential as targets for pharmacological intervention in a number of other diseases. Thus, inhibitors of these enzymes have received considerable attention, but these are often evaluated by IC50 value determination, which may vary significantly depending on assay conditions. In this work, we therefore performed detailed kinetic evaluation of inhibitors containing two fundamentally different zinc-binding chemotypes, hydroxamic acid or trifluoromethyl ketone. For the hydroxamic acids, a fast-on–fast-off mechanism was observed, but the trifluoromethyl ketone compound exhibited differential mechanisms depending on the enzyme isoform. The trifluoromethyl ketone compound displayed a fast-on–fast-off mechanism against class-IIa HDACs 4 and 7, but slow-binding mechanisms against class-I and class-IIb enzymes (HDACs 1–3, 6 and 8). Furthermore, different competitive, slow-binding mechanisms were observed for HDACs 1, 2, and 6 vs. HDACs 3 and 8, demonstrating the power of kinetic experiments for characterisation of enzyme inhibitors.

U2 - 10.1039/c5md00451a

DO - 10.1039/c5md00451a

M3 - Journal article

VL - 7

SP - 464

EP - 470

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

ER -

ID: 166140088